- Home
- DNTH vs STNG Comparison
DNTH vs STNG Comparison
Compare DNTH & STNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | STNG |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | Monaco |
| Employees | N/A | 24 |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.0B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | DNTH | STNG |
|---|---|---|
| Price | $88.63 | $83.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $121.00 | $83.33 |
| AVG Volume (30 Days) | 523.2K | ★ 938.7K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.22% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,036,000.00 | N/A |
| Revenue This Year | N/A | $4.31 |
| Revenue Next Year | $29.48 | N/A |
| P/E Ratio | ★ N/A | $10.06 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.77 | $37.96 |
| 52 Week High | $96.50 | $82.75 |
Technical Indicators
Market Signals| Indicator | DNTH | STNG |
|---|---|---|
| Relative Strength Index (RSI) | 56.27 | 68.79 |
| Support Level | $33.94 | $72.41 |
| Resistance Level | $96.50 | N/A |
| Average True Range (ATR) | 4.02 | 2.85 |
| MACD | -1.21 | 0.62 |
| Stochastic Oscillator | 45.82 | 93.52 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
About STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.